Attenuating gene expression (AGE) for vaccine development

References

• Galán JE, Nakayama K, Curtiss R 3rd. Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene 1990; 94:29 - 35; http://dx.doi.org/10.1016/0378-1119(90)90464-3; PMID: 2227450
   PubMed Web of Science ®Google Scholar
• Piao HH, Tam VT, Na HS, Kim HJ, Ryu PY, Kim SY, et al. Immunological responses induced by asd and wzy/asd mutant strains of Salmonella enterica serovar Typhimurium in BALB/c mice. J Microbiol 2010; 48:486 - 95; http://dx.doi.org/10.1007/s12275-010-0023-z; PMID: 20799091
   PubMed Web of Science ®Google Scholar
• Bacon GA, Burrows TW, Yates M. The effects of biochemical mutation on the virulence of Bacterium typhosum: the virulence of mutants. Br J Exp Pathol 1950; 31:714 - 24; PMID: 14801354
   PubMed Web of Science ®Google Scholar
• Hoiseth SK, Stocker BA. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981; 291:238 - 9; http://dx.doi.org/10.1038/291238a0; PMID: 7015147
   PubMed Web of Science ®Google Scholar
• Hone DM, Tacket CO, Harris AM, Kay B, Losonsky G, Levine MM. Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine. J Clin Invest 1992; 90:412 - 20; http://dx.doi.org/10.1172/JCI115876; PMID: 1644914
   PubMed Web of Science ®Google Scholar
• Tacket CO, Hone DM, Losonsky GA, Guers L, Edelman R, Levine MM. Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain. Vaccine 1992; 10:443 - 6; http://dx.doi.org/10.1016/0264-410X(92)90392-W; PMID: 1609547
   PubMed Web of Science ®Google Scholar
• Robertsson JA, Lindberg AA, Hoiseth S, Stocker BA. Salmonella typhimurium infection in calves: protection and survival of virulent challenge bacteria after immunization with live or inactivated vaccines. Infect Immun 1983; 41:742 - 50; PMID: 6347895
   PubMed Web of Science ®Google Scholar
• Smith BP, Reina-Guerra M, Stocker BA, Hoiseth SK, Johnson E. Aromatic-dependent Salmonella dublin as a parenteral modified live vaccine for calves. Am J Vet Res 1984; 45:2231 - 5; PMID: 6395725
   PubMed Web of Science ®Google Scholar
• Jones PW, Dougan G, Hayward C, Mackensie N, Collins P, Chatfield SN. Oral vaccination of calves against experimental salmonellosis using a double aro mutant of Salmonella typhimurium.. Vaccine 1991; 9:29 - 34; http://dx.doi.org/10.1016/0264-410X(91)90313-U; PMID: 2008797
   PubMed Web of Science ®Google Scholar
• Alam J, Singh BR, Hansda D, Singh VP, Verma JC. Evaluation of aroA deletion mutant of Salmonella enterica subspecies enterica serovar Abortusequi for its vaccine candidate potential. Indian J Exp Biol 2009; 47:871 - 9; PMID: 20099460
   PubMed Web of Science ®Google Scholar
• Trebichavsky I, Splichalova A, Rychlik I, Hojna H, Muneta Y, Mori Y, et al. Attenuated aroA Salmonella enterica serovar Typhimurium does not induce inflammatory response and early protection of gnotobiotic pigs against parental virulent LT2 strain. Vaccine 2006; 24:4285 - 9; http://dx.doi.org/10.1016/j.vaccine.2006.02.054; PMID: 16584815
   PubMed Web of Science ®Google Scholar
• Barrow PA, Page K, Lovell MA. The virulence for gnotobiotic pigs of live attenuated vaccine strains of Salmonella enterica serovars Typhimurium and Enteritidis. Vaccine 2001; 19:3432 - 6; http://dx.doi.org/10.1016/S0264-410X(01)00065-2; PMID: 11348707
   PubMed Web of Science ®Google Scholar
• Lumsden JS, Kennedy BW, Mallard BA, Wilkie BN. The influence of the swine major histocompatibility genes on antibody and cell-mediated immune responses to immunization with an aromatic-dependent mutant of Salmonella typhimurium.. Can J Vet Res 1993; 57:14 - 8; PMID: 8431799
   PubMed Web of Science ®Google Scholar
• Van Immerseel F, De Buck J, De Smet I, Mast J, Haesebrouck F, Ducatelle R. The effect of vaccination with a Salmonella enteritidis aroA mutant on early cellular responses in caecal lamina propria of newly-hatched chickens. Vaccine 2002; 20:3034 - 41; http://dx.doi.org/10.1016/S0264-410X(02)00227-X; PMID: 12126917
   PubMed Web of Science ®Google Scholar
• Methner U, Barrow PA, Martin G, Meyer H. Comparative study of the protective effect against Salmonella colonisation in newly hatched SPF chickens using live, attenuated Salmonella vaccine strains, wild-type Salmonella strains or a competitive exclusion product. Int J Food Microbiol 1997; 35:223 - 30; http://dx.doi.org/10.1016/S0168-1605(96)01236-6; PMID: 9105931
   PubMed Web of Science ®Google Scholar
• Cooper GL, Venables LM, Woodward MJ, Hormaeche CE. Vaccination of chickens with strain CVL30, a genetically defined Salmonella enteritidis aroA live oral vaccine candidate. Infect Immun 1994; 62:4747 - 54; PMID: 7927750
   PubMed Web of Science ®Google Scholar
• Saxena M, Coloe PJ, Smooker PM. Influence of promoter, gene copy number, and preexisting immunity on humoral and cellular responses to a vectored antigen delivered by a Salmonella enterica vaccine. Clin Vaccine Immunol 2009; 16:78 - 87; http://dx.doi.org/10.1128/CVI.00253-08; PMID: 19005022
   PubMed Web of Science ®Google Scholar
• Xie C, He JS, Zhang M, Xue SL, Wu Q, Ding XD, et al. Oral respiratory syncytial virus (RSV) DNA vaccine expressing RSV F protein delivered by attenuated Salmonella typhimurium.. Hum Gene Ther 2007; 18:746 - 52; http://dx.doi.org/10.1089/hum.2007.053; PMID: 17696764
   PubMed Web of Science ®Google Scholar
• Medina E, Guzmán CA, Staendner LH, Colombo MP, Paglia P. Salmonella vaccine carrier strains: effective delivery system to trigger anti-tumor immunity by oral route. Eur J Immunol 1999; 29:693 - 9; http://dx.doi.org/10.1002/(SICI)1521-4141(199902)29:02<693::AID-IMMU693>3.0.CO;2-V; PMID: 10064087
   PubMed Web of Science ®Google Scholar
• Fouts TR, Tuskan RG, Chada S, Hone DM, Lewis GK. Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120. Vaccine 1995; 13:1697 - 705; http://dx.doi.org/10.1016/0264-410X(95)00106-B; PMID: 8719522
   PubMed Web of Science ®Google Scholar
• Salomonsson E, Kuoppa K, Forslund AL, Zingmark C, Golovliov I, Sjöstedt A, et al. Reintroduction of two deleted virulence loci restores full virulence to the live vaccine strain of Francisella tularensis.. Infect Immun 2009; 77:3424 - 31; http://dx.doi.org/10.1128/IAI.00196-09; PMID: 19506014
   PubMed Web of Science ®Google Scholar
• O’Callaghan D, Maskell D, Liew FY, Easmon CS, Dougan G. Characterization of aromatic- and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice. Infect Immun 1988; 56:419 - 23; PMID: 3276625
   PubMed Web of Science ®Google Scholar
• Galán JE, Curtiss R 3rd. Virulence and vaccine potential of phoP mutants of Salmonella typhimurium.. Microb Pathog 1989; 6:433 - 43; http://dx.doi.org/10.1016/0882-4010(89)90085-5; PMID: 2671582
   PubMed Web of Science ®Google Scholar
• Hohmann EL, Oletta CA, Miller SI. Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. Vaccine 1996; 14:19 - 24; http://dx.doi.org/10.1016/0264-410X(95)00173-X; PMID: 8821644
   PubMed Web of Science ®Google Scholar
• Garmory HS, Brown KA, Titball RW. Salmonella vaccines for use in humans: present and future perspectives. FEMS Microbiol Rev 2002; 26:339 - 53; PMID: 12413664
   PubMed Web of Science ®Google Scholar
• Hohmann EL, Oletta CA, Killeen KP, Miller SI. phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. J Infect Dis 1996; 173:1408 - 14; http://dx.doi.org/10.1093/infdis/173.6.1408; PMID: 8648213
   PubMed Web of Science ®Google Scholar
• Bowe F, O’Gaora P, Maskell D, Cafferkey M, Dougan G. Virulence, persistence, and immunogenicity of Yersinia enterocolitica O:8 aroA mutants. Infect Immun 1989; 57:3234 - 6; PMID: 2777382
   PubMed Web of Science ®Google Scholar
• Oyston PC, Dorrell N, Williams K, Li SR, Green M, Titball RW, et al. The response regulator PhoP is important for survival under conditions of macrophage-induced stress and virulence in Yersinia pestis.. Infect Immun 2000; 68:3419 - 25; http://dx.doi.org/10.1128/IAI.68.6.3419-3425.2000; PMID: 10816493
   PubMed Web of Science ®Google Scholar
• Foulongne V, Walravens K, Bourg G, Boschiroli ML, Godfroid J, Ramuz M, et al. Aromatic compound-dependent Brucella suis is attenuated in both cultured cells and mouse models. Infect Immun 2001; 69:547 - 50; http://dx.doi.org/10.1128/IAI.69.1.547-550.2001; PMID: 11119550
   PubMed Web of Science ®Google Scholar
• Kato A, Groisman EA, Howard Hughes Medical Institute. The PhoQ/PhoP regulatory network of Salmonella enterica.. Adv Exp Med Biol 2008; 631:7 - 21; http://dx.doi.org/10.1007/978-0-387-78885-2_2; PMID: 18792679
   PubMed Web of Science ®Google Scholar
• Curtiss R 3rd, Wanda SY, Gunn BM, Zhang X, Tinge SA, Ananthnarayan V, et al. Salmonella enterica serovar typhimurium strains with regulated delayed attenuation in vivo.. Infect Immun 2009; 77:1071 - 82; http://dx.doi.org/10.1128/IAI.00693-08; PMID: 19103774
   PubMed Web of Science ®Google Scholar
• Sun W, Roland KL, Kuang X, Branger CG, Curtiss R 3rd. Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague. Infect Immun 2010; 78:1304 - 13; http://dx.doi.org/10.1128/IAI.01122-09; PMID: 20086087
   PubMed Web of Science ®Google Scholar
• Curtiss R 3rd, Xin W, Li Y, Kong W, Wanda SY, Gunn B, et al. New technologies in using recombinant attenuated Salmonella vaccine vectors. Crit Rev Immunol 2010; 30:255 - 70; http://dx.doi.org/10.1615/CritRevImmunol.v30.i3.30; PMID: 20370633
   PubMed Web of Science ®Google Scholar
• Yang X, Suo Z, Thornburg T, Holderness K, Cao L, Lim T, et al. Expression of Escherichia coli virulence usher protein attenuates wild-type Salmonella.. Virulence 2012; 3:29 - 42; http://dx.doi.org/10.4161/viru.3.1.18447; PMID: 22286706
   PubMed Web of Science ®Google Scholar
• Cao L, Suo Z, Lim T, Jun S, Deliorman M, Riccardi C, et al. Role of overexpressed CFA/I fimbriae in bacterial swimming. Phys Biol 2012; 9:036005; http://dx.doi.org/10.1088/1478-3975/9/3/036005; PMID: 22562964
   PubMedGoogle Scholar
• Yang X, Thornburg T, Holderness K, Suo Z, Cao L, Lim T, et al. Serum antibodies protect against intraperitoneal challenge with enterotoxigenic Escherichia coli. J Biomed Biotechnol 2011; 2011:632396; http://dx.doi.org/10.1155/2011/632396; PMID: 22007145
   PubMed Web of Science ®Google Scholar
• Suo Z, Avci R, Deliorman M, Yang X, Pascual DW. Bacteria survive multiple puncturings of their cell walls. Langmuir 2009; 25:4588 - 94; http://dx.doi.org/10.1021/la8033319; PMID: 19260649
   PubMed Web of Science ®Google Scholar
• Evans DG, Satterwhite TK, Evans DJ Jr., DuPont HL. Differences in serological responses and excretion patterns of volunteers challenged with enterotoxigenic Escherichia coli with and without the colonization factor antigen. Infect Immun 1978; 19:883 - 8; PMID: 346488
   PubMed Web of Science ®Google Scholar
• Cao L, Lim T, Jun S, Thornburg T, Avci R, Yang X. Vulnerabilities in Yersinia pestis caf operon are unveiled by a Salmonella vector. PLoS One 2012; 7:e36283; http://dx.doi.org/10.1371/journal.pone.0036283; PMID: 22558420
   PubMed Web of Science ®Google Scholar
• Yang X, Thornburg T, Suo Z, Jun S, Robison A, Li J, et al. Flagella overexpression attenuates Salmonella pathogenesis. PLoS One 2012; 7:e46828; http://dx.doi.org/10.1371/journal.pone.0046828; PMID: 23056473
   PubMed Web of Science ®Google Scholar
• Yang X, Hinnebusch BJ, Trunkle T, Bosio CM, Suo Z, Tighe M, et al. Oral vaccination with salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague. J Immunol 2007; 178:1059 - 67; PMID: 17202369
   PubMed Web of Science ®Google Scholar
• Yang X, Thornburg T, Walters N, Pascual DW. DeltaznuADeltapurE Brucella abortus 2308 mutant as a live vaccine candidate. Vaccine 2010; 28:1069 - 74; http://dx.doi.org/10.1016/j.vaccine.2009.10.113; PMID: 19914192
   PubMed Web of Science ®Google Scholar
• Yang X, Skyberg JA, Cao L, Clapp B, Thornburg T, Pascual DW. Progress in Brucella vaccine development. Front Biol 2013; 8:60 - 77; http://dx.doi.org/10.1007/s11515-012-1196-0
   Google Scholar
• Yang X, Becker T, Walters N, Pascual DW. Deletion of znuA virulence factor attenuates Brucella abortus and confers protection against wild-type challenge. Infect Immun 2006; 74:3874 - 9; http://dx.doi.org/10.1128/IAI.01957-05; PMID: 16790759
   PubMed Web of Science ®Google Scholar
• Mizel SB, Bates JT. Flagellin as an adjuvant: cellular mechanisms and potential. J Immunol 2010; 185:5677 - 82; http://dx.doi.org/10.4049/jimmunol.1002156; PMID: 21048152
   PubMed Web of Science ®Google Scholar
• Mizel SB, Graff AH, Sriranganathan N, Ervin S, Lees CJ, Lively MO, et al. Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates. Clin Vaccine Immunol 2009; 16:21 - 8; http://dx.doi.org/10.1128/CVI.00333-08; PMID: 18987167
   PubMed Web of Science ®Google Scholar
• Pecota DC, Kim CS, Wu K, Gerdes K, Wood TK. Combining the hok/sok, parDE, and pnd postsegregational killer loci to enhance plasmid stability. Appl Environ Microbiol 1997; 63:1917 - 24; PMID: 9143123
   PubMed Web of Science ®Google Scholar
• Gerdes K, Thisted T, Martinussen J. Mechanism of post-segregational killing by the hok/sok system of plasmid R1: sok antisense RNA regulates formation of a hok mRNA species correlated with killing of plasmid-free cells. Mol Microbiol 1990; 4:1807 - 18; http://dx.doi.org/10.1111/j.1365-2958.1990.tb02029.x; PMID: 1707122
   PubMed Web of Science ®Google Scholar
• Mellies J, Wise A, Villarejo M. Two different Escherichia coli proP promoters respond to osmotic and growth phase signals. J Bacteriol 1995; 177:144 - 51; PMID: 8002611
   PubMed Web of Science ®Google Scholar